Alembic Pharmaceuticals appoints Ramesh Juneja as Executive VP – Human Health for India business Read more
Alembic Pharmaceuticals receives USFDA approval for Lamotrigine Orally Disintegrating tablets Read more
Alembic Pharmaceuticals gets USFDA final approval for Travoprost Ophthalmic Solution USP, 0.004% Read more
Alembic Pharmaceuticals receives USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension Read more